Arrowhead Research Corporation (ARWR)

NASDAQ

$57.68

$-0.99

(-1.68%)

Regular Market

Arrowhead Research Corporation (ARWR) Live Price Chart

Last updated: ⁦2026-10-22 18:00:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Arrowhead Research Corporation (ARWR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $57.68, with a market capitalization of $8.32B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $36.73 to $95.49. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$8.32B
Open	$58.06
Day's High	$95.49
Day's Low	$1.20
Previous Close	$58.84
Volume	383.73K
Average Volume	1.78M
P/E Ratio	--
52-Week High	$95.49
52-Week Low	$36.73
Dividend Yield	--
Earnings Date	2001-09-29

Arrowhead Research Corporation (ARWR) Stock Price Today

Arrowhead Research Corporation (ARWR) is currently trading at $57.68 as of 2026-10-22 17:59:00, down 1.97% ($1.16) from the previous close of $58.84

During today's regular trading session, ARWR has traded between $1.20 and $95.49, with a trading volume of 383.73K shares. The current price is near the middle of today's range.

Arrowhead Research Corporation (ARWR) 7-Day Stock Price Change

Over the past seven days, Arrowhead Research Corporation (ARWR) moved from $58.13 to $57.68, representing a decline of 0.77% ($0.45).

The stock traded between $55.83 and $60.73 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 2.14 million shares, up versus the previous seven-day period, indicating higher trading activity.

ARWR 52-Week Price Position

Position in Range: 35.7%

52W Low$36.73

52W High$95.49

ARWR is currently trading at $57.68, placing it 35.7% of the way from its 52-week low of $36.73 to its 52-week high of $95.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Arrowhead Research Corporation (ARWR)?

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Arrowhead Research Corporation Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	711
CEO	Christopher R. Anzalone
Founded	2003
Exchange	NASDAQ
Company Website	https://www.arrowheadpharma.com

How to Buy Arrowhead Research Corporation (ARWR) Stock on MEXC

Eligible investors can buy real shares of Arrowhead Research Corporation (ARWR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ARWR and Place Your Order

Open the RealStocks trading page and search for ARWR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Arrowhead Research Corporation (ARWR) stock price today?

Arrowhead Research Corporation (ARWR) is currently trading at $ 57.68, down 1.97% ($1.16) from the previous close of $ 58.84. Intraday prices update in real time during regular trading hours.

2.Is ARWR stock going up or down today?

As of 2026-10-22 17:59:00, ARWR is trading at $ 57.68, down 1.97% ($1.16) from its previous close of $ 58.84. The stock has traded between $ 1.20 and $ 95.49 during today’s regular session. Past price movements do not guarantee future results.

3.What is ARWR pre-market price?

As of 2026-10-22 17:59:00, ARWR is trading at $ 58.55 in pre-market trading, down 0.49% ($0.29) from the previous close of $ 58.84. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ARWR after-hours price?

As of 2026-10-22 17:59:00, ARWR is trading at $ 59.27 in after-hours trading, up 0.74% ($0.43) from the regular-session close of $ 58.84. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ARWR stock trading now?

ARWR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ARWR sit relative to its 52-week high and low?

Over the past 52 weeks, ARWR has traded between a low of $ 36.73 and a high of $ 95.49. At $ 57.68, the stock is positioned 35.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Arrowhead Research Corporation in?

Arrowhead Research Corporation (ARWR) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Arrowhead Research Corporation's market capitalization and where is it listed?

Arrowhead Research Corporation is listed on the NASDAQ exchange with a market capitalization of $ 8.32B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ARWR valued in terms of P/E ratio and EPS?

ARWR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.27. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Arrowhead Research Corporation pay a dividend?

Arrowhead Research Corporation pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.